Strategic Advisors LLC Vertex Pharmaceuticals Inc Transaction History
Strategic Advisors LLC
- $510 Million
- Q1 2025
A detailed history of Strategic Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Strategic Advisors LLC holds 4,580 shares of VRTX stock, worth $2.29 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
4,580
Previous 4,486
2.1%
Holding current value
$2.29 Million
Previous $1.81 Million
22.92%
% of portfolio
0.44%
Previous 0.33%
Shares
5 transactions
Others Institutions Holding VRTX
# of Institutions
1,807Shares Held
225MCall Options Held
1.61MPut Options Held
1.43M-
Capital World Investors Los Angeles, CA28.5MShares$14.3 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$11.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.7 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$7.27 Billion1.6% of portfolio
-
State Street Corp Boston, MA12MShares$5.99 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $128B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...